https://doctransparency.com/doctor/tx/houston/rahul-sheth-1932337979
Medicare Enrolled

Dr. Rahul Sheth, M.D.

Radiation Oncology · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
1515 HOLCOMBE BLVD, Houston, TX 77030
7137926161
In practice since 2009 (16 years)
NPI: 1932337979 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sheth from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sheth? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sheth

Dr. Rahul Sheth is a radiation oncology in Houston, TX, with 16 years in practice. Based on federal Medicare data, Dr. Sheth performed 249 Medicare services across 214 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sheth received a total of $284,022 from 25 pharmaceutical and/or device companies across 374 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sheth is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ 249 Medicare services$ $284,022 industry payments

Medicare Practice Summary

Medicare Utilization ↗
249
Medicare services
Bottom 10% in TX for radiation oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
214
Unique beneficiaries
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~16 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Chest X-ray, 1 view38$7$87
Office visit, established patient (20-29 min)36$53$172
Ct guidance for tissue removal25$146$1,534
Review by radiologist of ct guidance for needle placement24$57$518
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes24$10$120
Ultrasonic guidance for blood vessel access18$12$151
Office visit, established patient (30-39 min)18$74$265
Freezing of growth of bone and adjacent soft tissue16$258$3,601
Destruction of growth of liver through skin using radiofrequency13$570$5,701
Ultrasonic guidance for needle placement13$25$396
Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch12$120$2,843
Occlusion of growths or obstructed vessels with review by radiologist12$354$8,732
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$284,022
Total received (2018-2024)
Avg $40,575/year across 7 years
Top 0% in TX for radiation oncology
25
Companies
374
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$197,399 (69.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$43,447 (15.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$43,176 (15.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$134,256
2023
$54,541
2022
$32,649
2021
$13,324
2020
$12,516
2019
$31,838
2018
$4,899

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$78,082
Medtronic, Inc.
$59,882
Inari Medical, Inc.
$47,229
TriSalus Life Sciences, Inc.
$26,279
Siemens Medical Solutions USA, Inc.
$21,812
PFIZER INC.
$16,631
Medtronic USA, Inc.
$16,155
Bard Peripheral Vascular, Inc.
$5,999
Varian Medical Systems, Inc.
$3,675
GUERBET LLC
$3,383
Vertiflex, Inc.
$1,375
Janssen Research & Development, LLC
$1,080
Becton, Dickinson and Company
$827
Endocare, Inc.
$412
Stryker Corporation
$401
Penumbra, Inc.
$170
Galvanize Therapeutics, Inc
$149
BOSTON SCIENTIFIC CORPORATION
$149
Actelion Pharmaceuticals US, Inc.
$130
W. L. Gore & Associates, Inc.
$83
Abbott Laboratories
$36
Novartis Pharmaceuticals Corporation
$30
Janssen Pharmaceuticals, Inc
$20
E.R. Squibb & Sons, L.L.C.
$20
Medical Device Business Services, Inc.
$15
Top 3 companies account for 65.2% of total payments
Associated products mentioned in payments ›
ABRE · ALIYA SYSTEM · Artis icono floor · Artis pheno · BAVENCIO · CAMZYOS · CONCERTOTM · CT THROMBECTOMY SYSTEM KIT · Certus 140 · EMBOLD Fibered · EMPRINT · ENSITE · ENSITE PRECISION · FLOWTRIEVER CATHETER · GENERAL - THERAPIES · GENERAL - VASCULAR INTERVENTION · GENERAL VASCULAR INTERVENTION · General - BPH · General - IO Ablation · General - Therapies · General - Vascular Intervention · INTELLIS ADAPTIVESTIM · Indigo System · KYPHON Balloon Kyphoplasty · KYPHON EXPRESS II KYPHOPAK TRAY · LEQVIO · LIPIODOL · Lipiodol · NAEOTOM Alpha · OBSIDIO · ONYX FRONTIER · OSTEOCOOL RF ABLATION · OSTEOCOOL RF ABLATION SYSTEM · RESOLUTE ONYX · S · SOMATOM Force · SPINEJACK · SUTENT · SYNCHROMEDII · Superion ISS · TRINAV INFUSION SYSTEM · TheraSphere Y90 Glass Microspheres 10 GBq · TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) · UPTRAVI · VIABAHN VBX Balloon Expandable Endoprosthesis · Varian CRYOCARE TOUCH System · Varian Treatment · Visual-ICE Cryoablation System · Visual-ICE MRI Cryoablation Console · Watchman · XARELTO · syngo.via
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (70%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in radiation oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for radiation oncology in TX.

Equivalent to $114,065 per 100 Medicare services performed
Looking for a radiation oncology in Houston?
Compare radiation oncologys in the Houston area by procedure volume, costs, and industry payment transparency.
Browse radiation oncologys nearby

Geographic Context

Radiation Oncologys within 10 mi
765
Per 100K population
16.1
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Sheth is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 0%), with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Sheth experienced with chest x-ray, 1 view?
Based on Medicare claims data, Dr. Sheth performed 38 chest x-ray, 1 view services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sheth receive payments from pharmaceutical companies?
Yes. Dr. Sheth received a total of $284,022 from 25 companies across 374 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sheth's costs compare to other radiation oncologys in Houston?
Dr. Sheth's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sheth) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →